Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway

BACKGROUND: Dulaglutide, a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), has been shown to reduce body weight and liver fat content in patients with type 2 diabetes. Family with sequence similarity 3 member A (FAM3A) plays a vital role in regulating glucose and lipid metabolism. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jinmi, Hong, Seok-Woo, Kim, Min-Jeong, Moon, Sun Joon, Kwon, Hyemi, Park, Se Eun, Rhee, Eun-Jung, Lee, Won-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901965/
https://www.ncbi.nlm.nih.gov/pubmed/35144334
http://dx.doi.org/10.3803/EnM.2021.1293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901965/
https://www.ncbi.nlm.nih.gov/pubmed/35144334
http://dx.doi.org/10.3803/EnM.2021.1293

Ejemplares similares